• 1. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148

Propanamide, N-(4-ethynylphenyl)- (CAS No. 874379-93-8): A Comprehensive Overview in Modern Chemical Research

Propanamide, N-(4-ethynylphenyl)-, identified by its unique chemical identifier CAS No. 874379-93-8, represents a significant compound in the realm of advanced chemical synthesis and pharmaceutical applications. This compound, characterized by its structural motif of a propylamide group linked to a phenyl ring substituted with an ethynyl group at the para position, has garnered considerable attention due to its versatile reactivity and potential utility in various scientific domains.

The molecular structure of Propanamide, N-(4-ethynylphenyl)- encompasses both functional groups that are highly relevant to modern synthetic chemistry. The presence of the amide functionality (-CONH-) provides a site for further derivatization, enabling the creation of more complex molecules through reactions such as nucleophilic substitution or condensation reactions. Concurrently, the ethynyl group (-C≡CH) introduces a reactive site that is amenable to Sonogashira coupling reactions, allowing for the introduction of aryl or vinyl groups at specific positions within the molecule.

In recent years, the pharmaceutical industry has shown increasing interest in amide-based compounds due to their demonstrated biological activity. Specifically, amides have been identified as key structural elements in numerous drugs that target various therapeutic pathways. The compound Propanamide, N-(4-ethynylphenyl)- is no exception and has been explored in several preclinical studies for its potential role as an intermediate in the synthesis of novel therapeutic agents.

One of the most compelling aspects of Propanamide, N-(4-ethynylphenyl)- is its utility in medicinal chemistry. The combination of the amide and ethynyl groups offers a scaffold that can be modified to produce molecules with tailored biological properties. For instance, researchers have utilized this compound to develop derivatives that exhibit inhibitory effects on specific enzymes implicated in inflammatory responses. These derivatives have shown promise in models of chronic inflammation, suggesting their potential as leads for new anti-inflammatory therapies.

The synthetic methodologies employed in the preparation of Propanamide, N-(4-ethynylphenyl)- are also noteworthy. The synthesis typically involves the reaction of 4-bromoacetophenone with sodium propargolate in the presence of a palladium catalyst, followed by hydrolysis to yield the desired amide. This approach leverages cross-coupling reactions, which are cornerstone techniques in modern organic synthesis. The use of palladium catalysts not only facilitates these reactions but also allows for high selectivity and yield, making it an attractive method for industrial-scale production.

Beyond pharmaceutical applications, Propanamide, N-(4-ethynylphenyl)- has found utility in materials science and agrochemical research. Its unique structural features make it a valuable building block for designing novel materials with specific electronic or optical properties. Additionally, derivatives of this compound have been investigated for their potential as bioactive agents in crop protection applications.

The investigation into the biological activity of Propanamide, N-(4-ethynylphenyl)- has revealed several interesting findings. In vitro studies have demonstrated that certain derivatives exhibit moderate affinity for enzymes involved in metabolic pathways relevant to neurodegenerative diseases. These findings have prompted further exploration into the development of small-molecule modulators based on this scaffold.

The role of computational chemistry in understanding the properties of Propanamide, N-(4-ethynylphenyl)- cannot be overstated. Advanced computational techniques such as molecular dynamics simulations and quantum mechanical calculations have provided insights into its interactions with biological targets at an atomic level. These studies have not only helped refine synthetic strategies but also guided the design of more potent and selective derivatives.

In conclusion, Propanamide, N-(4-ethynylphenyl)- (CAS No. 874379-93-8) stands as a testament to the ingenuity and versatility of modern chemical research. Its multifaceted applications span across pharmaceuticals, materials science, and agrochemicals, underscoring its importance as a versatile intermediate and building block. As research continues to uncover new possibilities for this compound and its derivatives, its significance is poised to grow even further.

• 35447-83-7(N-(4-Ethynylphenyl)acetamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)